Welcome to our dedicated page for AGI news (Ticker: AGBK), a resource for investors and traders seeking the latest updates and insights on AGI stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AGI's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AGI's position in the market.
Brazilian fintech AGI (NYSE: AGBK) opened for trading on Feb 11, 2026 after completing an IPO that raised $240 million. The NYSE pre-market update noted AGBK’s opening bell appearance and highlighted broader market context, including the Dow closing above 50,000 and a delayed January jobs report.
The same NYSE update also noted Scotts Miracle-Gro (NYSE: SMG) marking its 30th anniversary with a closing bell celebration.
AGI (NYSE:AGBK) priced its initial public offering of 20,000,000 Class A shares at US$12.00 per share, with trading expected to begin on February 11, 2026 and closing expected on February 12, 2026, subject to customary closing conditions.
The company granted underwriters a 30-day option to buy up to an additional 3,000,000 shares. Global coordinators include Goldman Sachs and Morgan Stanley.
FAQ
What is the current stock price of AGI (AGBK)?
What is the market cap of AGI (AGBK)?
